La Jolla Labs was founded to make modern RNA biology and advanced computational techniques directly useful to patients whose ...

Researchers have developed a nanoparticle platform that can deliver mRNA therapy to affected cartilage based on ...

The global automated nucleic acid extraction market size was valued at US$ 3.6 Bn in 2025 and is projected to reach US$ 11.7 ...

CRISPR–Cas9-based therapies are widely investigated for their clinical applications. However, there are limitations ...

The two IPOs, which follow radiopharma specialist Aktis Oncology's filing last week, have investors and industry watchers ...

A new review highlights major advances in a promising class of diagnostic tools known as aptamer-based biosensors, which ...

This study presents a comprehensive approach for assessing multiple quality attributes of antibody-oligonucleotide conjugates ...

The n-Lorem Foundation and the EspeRare Foundation announced today a strategic collaboration to expand access in Europe to ...

Pharma industry experts indicate that strategy in 2026 is shifting to agentic AI, sustainable efficiency, and resilient supply chains to manage tariffs, regulations, and digitalization.

Extracellular vesicles (EVs), including exosomes, microvesicles, apoptotic bodies, and many other EV subtypes, have emerged ...

WASHINGTON - We're deep into cold and flu season, and you're likely reaching for any immune-boosting foods you can find.